Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-02-26 @ 11:00 AM
Study NCT ID:
NCT02831660
Status:
COMPLETED
Last Update Posted:
2018-03-20
First Post:
2016-07-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
CU Programme of Idarucizumab for Japanese Patients
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1321.14
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None